NOF EUROPE
   

1     Introduction
MODIPER® A Series is a group of novel type graft copolymers, consisting of polyolefin as a main-chain
and vinyl related (co)polymers as a branch polymer, which are exclusively manufactured by NOF
CORPORATION utilizing NOF's newly developed grafting technology.
MODIPER® A Series opens new world of polymer and elastomer modification and gives you great gift to
your products.



2     Typical Applications of MODIPER® A Series
Impact Modifier (PBT, PPS, etc.)
Compatibilizer for various poolymer blends (PBT/ABS, PBT/PC, PC/ABS, etc.)
Tribological property improver (POM, PBT, PC, PC/ABS, PPE, PPS, PA, HIPS, etc.)
Modability improver for Blow-molding or Extrusion molding.
Anti-solventability improver for ABS and etc..
Dispersant of Frame-retardant, Inorganic fillers, pigment or additives.
Mechanical (modulus, strength, etc.) or thermal property improver.
and so on.

3     Standard Grades of MODIPER® A Series


4     Tribological properties of PC or PA66 improved with MODIPER® A1401


5     Improvement of Impact Strength of PBT with MODIPER® A4300


6     Contact

NOF CORPORATION, Functional Chemicals & Polymers Division, Fine Polymer department
   Yebisu Garden Place Tower, 20-3 Ebisu 4-chome, Shibuya-ku, Tokyo 150-6019, Japan
   Tel. +83-3-5424-6838   Fax. +81-3-5424-6814
   E-mail; modiper@nof.co.jp   URL: http://finepolymer.nof.co.jp/


NOF Europe(Belgium) N.V.
   Bouwelven 1, BE-2280 Grobbendonk, Belgium
   Tel. +32-14-25-98-29   Fax. +32-14-22-45-63









What's New
DDS

2010/07/26 Program for Liposome Conference in Vancouver, Aug 4-8, 2010
PDF

2010/07/08 NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010

2010/06/30
NOF release New Activated PEG

2010/05/21 NOF AMERICA CORPORATION opened a new office in California

On May 7, NOF AMERICA CORPORATION, a wholly owned subsidiary of NOF,
opened a new office in California to further enhance its sales
activities in the North American market
Post Address: 2102 Business Center Drive, Suite 130 Irvine, CA 92612, USA

2010/03/11 NOF partners with ENZON on PEG derivatives PDF

2010/01/07 NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery PDF